Last reviewed · How we verify
CHF6467 active
At a glance
| Generic name | CHF6467 active |
|---|---|
| Sponsor | Chiesi Farmaceutici S.p.A. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Safety and Efficacy of the PAINLESS Nerve Growth Factor CHF6467 in Optic Pathway Glioma (OPG) (PHASE2)
- CHF6467 SAD and MAD in Patients With Diabetic Foot Ulcer (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |